Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
icon
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Sana Biotechnology Inc (SANA) – Sana Biotechnology Inc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

SANA Biotechnology trades at $3.13, up 2.29% with a bearish technical signal despite strong analyst support (82% buy ratings). The company shows significant financial challenges with negative ROE of -147.41% and net income of -$244.17M for 2025, though cash burn improved from -$55M to -$12M projected for 2026. Recent developments include promising preclinical data for SG293 CAR T therapy and a strategic collaboration with Mayo Clinic.
While analyst consensus remains bullish with an $8 price target, SANA faces substantial execution risks as a pre-revenue biotech. The stock offers high-risk/high-reward potential dependent on clinical success, with current valuation reflecting both scientific promise and financial strain from ongoing R&D investments.
Read full analysis

Key Stats

  • Market Cap
    $871.05M
  • Sector
    Health
  • 3M Drawdown
    -35.42%
  • Enterprise Value
    $845.24M
  • Dividend Yield
    -
  • Trading Activity
    89% Buy | 11% Sell
  • Typical Hold Time
    8 days
$3.3
52W Low: $2.17
30 May 2025
52W High: $5.92
15 Oct 2025

Sana Biotechnology Inc (SANA) is currently valued at a market capitalization of $871.05M, with an enterprise value of $845.24M. Over the past 52 weeks, Sana Biotechnology Inc has traded between a low of $2.17 and a high of $5.92, highlighting its annual price range. Over the past three months, Sana Biotechnology Inc has recorded a drawdown of -35.42%, reflecting recent price volatility. On average, investors hold Sana Biotechnology Inc for approximately 8 days, indicating typical investor behavior on the platform.

About Sana Biotechnology Inc

Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.



People also bought


Global US Market Prices


Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Key Stats

  • Market Cap
    $871.05M
  • Sector
    Health
  • 3M Drawdown
    -35.42%
  • Enterprise Value
    $845.24M
  • Dividend Yield
    -
  • Trading Activity
    89% Buy | 11% Sell
  • Typical Hold Time
    8 days
$3.3
52W Low: $2.17
30 May 2025
52W High: $5.92
15 Oct 2025

Sana Biotechnology Inc (SANA) is currently valued at a market capitalization of $871.05M, with an enterprise value of $845.24M. Over the past 52 weeks, Sana Biotechnology Inc has traded between a low of $2.17 and a high of $5.92, highlighting its annual price range. Over the past three months, Sana Biotechnology Inc has recorded a drawdown of -35.42%, reflecting recent price volatility. On average, investors hold Sana Biotechnology Inc for approximately 8 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!